Video. Second Alzheimer's slowing drug to seek approval in the US
Donanemab has proven to slow disease progression by several months in some patients but has also shown serious side effects.
Read full articleDonanemab has proven to slow disease progression by several months in some patients but has also shown serious side effects.
Read full article